Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 May 15;205(10):1142-1144.
doi: 10.1164/rccm.202202-0393ED.

Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel

Christoph Lange  1   2   3   4 , Clifton E Barry 3rd  5 , C Robert Horsburgh Jr  6   7
Affiliations
Editorial

Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel

Christoph Lange et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. World Health Organization. Global tuberculosis report 2021. Geneva, Switzerland: 2021.
    1. Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda K. Drug-resistant tuberculosis: an update on disease burden, diagnosis and treatment. Respirology . 2018;23:656–673. - PubMed
    1. Lange C, Dheda K, Chesov D, Mandalakas AM, Udwadia Z, Horsburgh CR., Jr Management of drug-resistant tuberculosis. Lancet . 2019;394:953–966. - PMC - PubMed
    1. De Jager V, Gupte N, Nunes S, Barnes GL, van Wijk RC, Mostert J, et al. COMRADE Study Team Early bactericidal activity of meropenem plus clavulanate (with or without rifampin) for tuberculosis: the COMRADE randomized, phase 2A clinical trial. Am J Respir Crit Care Med . 2022;205:1228–1235. - PMC - PubMed
    1. Diacon AH, Pym A, Grobusch M, Patientia R, Rustomjee R, Page-Shipp L, et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med . 2009;360:2397–2405. - PubMed

Publication types

MeSH terms

Substances